Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22 Pharmaceutical Investing
Q4 FY23 Quarterly Report and Appendix 4C: Net Cash Used in Operating Activities Down 56% YoY to Record Low SmartNews
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030 Medical Device Investing
CABTREO Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S. Pharmaceutical Investing
